AUS
NZ
UK
CA
USA
IND
Healthcare
Algorae Pharmaceuticals (ASX:1AI) Rises as Cash Burn Eases
March 25, 2026 04:41 PM AEDT| By SamAlgorae Pharmaceuticals trends within all ordinaries show controlled cash usage, funding considerations, and biotechnology sector movement as development progresses without established revenue streams.
4DMedical Gains Momentum with Landmark US Healthcare Expansion
March 25, 2026 04:24 PM AEDT| By Sam4DMedical advances its US expansion through a key hospital collaboration, strengthening clinical validation and accelerating adoption of its lung imaging technology across prominent healthcare institutions.
Algorae Pharmaceuticals (ASX:1AI) Trends in the All Ordinaries
March 25, 2026 03:54 PM AEDT| By SamAlgorae Pharmaceuticals (ASX:1AI) emphasizes research, cash oversight, and sector positioning, contextualized by movements in the all ordinaries chart and broader ASX developments.
4DMedical (ASX:4DX) Advances Healthcare Imaging
March 25, 2026 02:57 PM AEDT| By Sam4DMedical’s engagement with Mayo Clinic highlights advancements in respiratory imaging and reflects healthcare innovation within the All Ordinaries market framework.
Is Algorae Pharma (ASX:1AI) shaping All Ords biotech focus?
March 25, 2026 01:00 PM AEDT| By SamAlgorae Pharmaceuticals highlights biotech sector activity within All Ordinaries, reflecting research-driven development and healthcare innovation in Australian markets.
ASX Small Caps Highlight Sector Expansion
March 24, 2026 07:26 PM AEDT| By SamASX small-cap activity highlights healthcare innovation and resource exploration, with companies like Recce and American Rare Earths shaping sector developments.
Telix Pharma Gains Traction on Radiopharma Progress
March 24, 2026 05:14 PM AEDT| By SamTelix Pharmaceuticals advances its radiopharma pipeline with key trial updates, strengthening its position in oncology innovation and drawing attention across broader ASX indices.
Recce Expands Global Patent Reach with Brazil Win
March 24, 2026 04:32 PM AEDT| By SamRecce Pharmaceuticals Ltd expands its global footprint with a Brazil patent, strengthening its anti-infectives platform and supporting innovation in treating bacterial and viral infections worldwide.
Emyria’s Mental Health Expansion Gains Momentum Ahead of Clinic Launch
March 24, 2026 12:29 PM AEDT| By SamMental health expansion gains traction as clinical readiness, workforce strength, and funded pathways align to support scalable healthcare delivery and improved patient access across Australia.
Echo IQ Gains Momentum on US Expansion Deal with Mayo Clinic
March 24, 2026 12:17 PM AEDT| By SamAI-driven healthcare innovation expands globally as advanced diagnostic tools integrate into hospital systems, highlighting regulatory progress, clinical validation, and growing demand for scalable solutions in modern medical ecosystems.
CHM.AX Crash Explained: What’s Driving Market Pressure Now
March 24, 2026 12:10 PM AEDT| By SamSharp movement in a biotech stock highlights liquidity risks, sector sentiment, and funding challenges, with future direction tied to clinical progress, market confidence, and broader healthcare trends.
Why CSL Faces Pressure While Pro Medicus Gains ASX 200 Focus
March 24, 2026 11:46 AM AEDT| By SamHealthcare sector shifts highlight innovation-led growth trends as established players face pressure while emerging technology-focused companies expand globally and strengthen their market presence.
Pro Medicus Update Sparks Fresh Valuation Debate
March 23, 2026 04:32 PM AEDT| By SamPro Medicus (ASX:PME) leadership changes spark renewed valuation debate as investors weigh growth outlook, premium pricing, and evolving healthcare imaging trends.
CSL Ltd (ASX:CSL) Holds Firm in ASX 50 on Continued Revenue Strength
March 23, 2026 03:55 PM AEDT| By SamCSL Ltd (ASX:CSL) delivers plasma, influenza, and renal treatments, maintains balanced financial metrics, and holds a key position among ASX 50 top companies.
Telix Pharmaceuticals (ASX:TLX) Advances Trials in ASX 100
March 23, 2026 03:49 PM AEDT| By SamTelix Pharmaceuticals (ASX:TLX) continues development of TLX101-Px and TLX591-Tx, highlighting regulatory progress and sector significance within the ASX 100.
Is Echo IQ (ASX:EIQ) Entry Reshaping ASX all ords?
March 23, 2026 03:05 PM AEDT| By SamEcho IQ joins the ASX all ords, reflecting increased healthcare technology participation and evolving market composition within Australia’s equity landscape.
Is Amplia Therapeutics (ASX:ATX) Advancing Cancer Trial Progress?
March 23, 2026 01:40 PM AEDT| By SamAmplia Therapeutics advances pancreatic cancer research through clinical trial progress, highlighting healthcare sector activity within the ASX All Ordinaries framework.
Island Pharma Share Move: What It Means Now
March 23, 2026 11:25 AM AEDT| By SamIsland Pharmaceuticals expands its share base through ASX quotation, highlighting capital flexibility and evolving liquidity dynamics within Australia’s healthcare-focused market environment.
ASX Healthcare Faces Pressure as Key Catalysts Drive Focus
March 20, 2026 05:48 PM AEDT| By SamASX healthcare stocks navigate macro pressures as clinical progress, regulatory updates, and innovation-driven milestones guide sector momentum and reshape market attention.
ASX 200 Update: Adherium Expands Through Share Move
March 20, 2026 04:38 PM AEDT| By Team Kalkine MediaAdherium strengthens its capital strategy through new share quotation, reflecting broader trends in healthcare innovation and evolving dynamics within Australia’s equity market.
Advertise your brand on Kalkine Media